Haynes J M, Cooper M E
Department of Medicine, University of Melbourne, Repatriation General Hospital, Heidelberg West, Victoria, Australia.
Eur J Pharmacol. 1995 Jun 23;280(1):91-4. doi: 10.1016/0014-2999(95)00230-i.
The effects of adrenomedullin and calcitonin gene-related peptide (CGRP) were compared in the rat isolated perfused kidney and in the anaesthetised rat. Adrenomedullin and CGRP both elicited concentration-dependent vasodilator responses from perfused kidneys (adrenomedullin was less potent than CGRP). These responses were blocked by CGRP-(8-37) (1 microM). Adrenomedullin and CGRP elicited dose-dependent hypotension in anaesthetised rats (adrenomedullin was less potent than CGRP). The hypotensive responses to CGRP, but not those to adrenomedullin, were antagonized by CGRP-(8-37) (12 nmol/kg/min). These studies indicate that the in vivo response to adrenomedullin may be mediated through CGRP-(8-37) insensitive receptors.
在大鼠离体灌注肾和麻醉大鼠中比较了肾上腺髓质素和降钙素基因相关肽(CGRP)的作用。肾上腺髓质素和CGRP均可引起灌注肾的浓度依赖性血管舒张反应(肾上腺髓质素的效力低于CGRP)。这些反应被CGRP-(8-37)(1微摩尔)阻断。肾上腺髓质素和CGRP在麻醉大鼠中引起剂量依赖性低血压(肾上腺髓质素的效力低于CGRP)。CGRP-(8-37)(12纳摩尔/千克/分钟)可拮抗对CGRP的低血压反应,但不能拮抗对肾上腺髓质素的反应。这些研究表明,体内对肾上腺髓质素的反应可能通过对CGRP-(8-37)不敏感的受体介导。